Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
AT1.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.20
N/A
-0.00
vs -0.00
Q2.21
N/A
-0.01
vs -0.01
Q4.21
N/A
-0.00
vs -0.00
Q2.22
N/A
-0.01
vs -0.01
Q4.22
N/A
-0.01
vs -0.00
Q2.23
N/A
-0.01
vs -0.01
Q4.23
N/A
-0.01
vs -0.01
Q2.24
N/A
-0.01
vs -0.01
Q4.24
N/A
-0.00
vs -0.01
Sales Growth
YoY
Current
Estimates
Q4.20
+388%
4.6M vs 937.3K
Q2.21
-52%
2.1M vs 4.4M
Q4.21
+17%
5.3M vs 4.6M
Q2.22
+227%
7M vs 2.1M
Q4.22
-75%
1.4M vs 5.3M
Q2.23
-83%
1.2M vs 7M
Q4.23
+42%
1.9M vs 1.4M
Q2.24
+83%
2.2M vs 1.2M
Q4.24
+7%
2.1M vs 1.9M
Return on Equity
QoQ
Q2.21
-12%
-0.12
vs -0.08
Q4.21
-9%
-0.09
vs -0.12
Q2.22
-13%
-0.13
vs -0.09
Q4.22
-30%
-0.30
vs -0.13
Q2.23
-28%
-0.28
vs -0.30
Q4.23
-23%
-0.23
vs -0.28
Q2.24
-37%
-0.37
vs -0.23
Q4.24
-37%
-0.37
vs -0.37
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
870%2025-Revenue
77%2025-EPS
-16140%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for COVID-19, HIV screening, pregnancy test, and respiratory test. The company was incorporated in 2010 and is headquartered in Leichhardt, Australia.
ASX
Unprofitable
EPS improving
Unprofitable
EPS improving
0.00Â ( 7.14%)
Relative Strenght
Volume Buzz
-29%
Earning Acce
No
Dist 52w H.
44%Relative Strength
AT1.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How AT1.AX compares to sector?